Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

The Dark Report

Kaiser, SBCL To Automate Pap Smear Screening

CEO SUMMARY: Two of the country’s largest Pap screen testing organizations are preparing to introduce automated primary screening into their laboratories. NeoPath’s con- tracts with SmithKline Beecham Clinical Laboratories and Kaiser Permanente mark the beginning of a new market cycle. NeoPath is poised to exploit these developments while continuing to enhance AutoPap’s capabilities. TWO OF …

Kaiser, SBCL To Automate Pap Smear Screening Read More »

To access this post, you must purchase The Dark Report.

Kaiser Plans Widespread Use For Pap Technology

WITHIN THE HMO INDUSTRY, Kaiser Permanente is highly respected for its thorough research into the clinical efficacy and economic cost of new healthcare technologies. That is the reason why Kaiser’s decision to adopt NeoPath, Inc.’s automated cytology technology for primary screening of Pap smears is getting widespread attention within the laboratory community. Coupled with a similar …

Kaiser Plans Widespread Use For Pap Technology Read More »

To access this post, you must purchase The Dark Report.

SBCL Makes System-Wide Commitment To AutoPap

SOMEONE ALWAYS HAS TO BE FIRST to adopt new technology. In the case of automated cytology, it will be SmithKline Beecham Clinical Laboratories (SBCL). SBCL and NeoPath, Inc. announced a four-year national agreement between the two companies on October 9 which will eventually allow SBCL to process 100% of its annual Pap smear volume using …

SBCL Makes System-Wide Commitment To AutoPap Read More »

To access this post, you must purchase The Dark Report.

PathSOURCE Is Newest Pathology Consolidator

CEO SUMMARY: Based in New York, PathSOURCE becomes the newest pathology network and services company to hit the market. PathSOURCE’s organizers want to link “best in class” dermatopathologists and academic pathology subspecialists to compete for outreach pathology specimens. PathSOURCE is further marketplace evidence that pathologists must innovate or find themselves underutilized. WITH THE GOAL OF …

PathSOURCE Is Newest Pathology Consolidator Read More »

To access this post, you must purchase The Dark Report.

People Make The Difference

IN THIS ISSUE THERE ARE STORIES ABOUT THE SUCCESSES of SmithKline Beecham Clinical Laboratories (SBCL) and UroCor. Each company has a lesson to teach us about developing a business strategy, then making it work in the marketplace. In the case of SBCL, I was astonished to realize that it has quietly become the sole source …

People Make The Difference Read More »

To access this post, you must purchase The Dark Report.

“October 19, 1998 Intelligence: Late Breaking Lab News”

Specialty Laboratories continues to make inroads as a national reference laboratory. Amerinet selected Specialty as a clinical laboratory service provider. It joins LabCorp and Quest on Amerinet’s laboratory provider panel. Specialty is aggressively repositioning itself from an esoterics provider to a routine esoterics provider. Earlier this year VHA added Specialty to its laboratory provider panel. …

“October 19, 1998 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

SBCL Inks National Pact With Aetna US Healthcare

CEO SUMMARY: As a corporate strategy, SmithKline Beecham Clinical Laboratories wants national contracts and exclusive provider status. The Aetna U.S. Healthcare agreement is SmithKline’s latest victory. Both companies are moving rapidly to implement the contract. In many cities where Aetna has a large presence, SmithKline expects to gain a significant increase in laboratory specimens. PERSISTENCE …

SBCL Inks National Pact With Aetna US Healthcare Read More »

To access this post, you must purchase The Dark Report.

SmithKline’s Strategies Now Delivering Benefits

CEO SUMMARY: Business strategy does make a difference. However, it sometimes takes years to appreciate the wisdom of choosing one strategy over another. In the case of SmithKline Beecham’s lab division, the decision to become sole-source provider to the nation’s largest HMOs may eventually prove to be a masterstroke. In coming years, sole-source arrangements may …

SmithKline’s Strategies Now Delivering Benefits Read More »

To access this post, you must purchase The Dark Report.

UroCor’s Sales Team Continues To Achieve New Sales Milestones

AT A TIME WHEN MANY clinical laboratories are experiencing a lack of growth, UroCor, Inc. of Oklahoma City continues its expansion of diagnostic services. Recently the company announced an important milestone. At the end of third quarter 1998, UroCor now services 2,500 of the nation’s 7, 500 office-based urologists. This gives UroCor a 33% penetration …

UroCor’s Sales Team Continues To Achieve New Sales Milestones Read More »

To access this post, you must purchase The Dark Report.

Washington State’s PacLab Network Is A Regional Winner

CEO SUMMARY: As a regional laboratory network, PacLab is unusual in one respect: participating hospital laboratories did not meet endlessly to talk about what they should do. Instead, action was the operative word for these network organizers. Since becoming operational in 1996, their bias for action has rewarded all participating laboratories. Test volumes are up …

Washington State’s PacLab Network Is A Regional Winner Read More »

To access this post, you must purchase The Dark Report.

;